Mazen Alsahli

2.2k citations
17 papers · 1.2k indexed · h-index 11
Topics
Inflammatory Bowel Disease (6 papers)Diabetes Treatment and Management (5 papers)Diabetes Management and Research (5 papers)

In The Last Decade

Mazen Alsahli

17 papers receiving 1.1k citations

Peers

Mazen Alsahli
Comparison fields: 5 of 94
  • Genetics 606
  • Epidemiology 465
  • Immunology 341
  • Endocrinology, Diabetes and Metabolism 291
  • Surgery 290
Replace Yoko Yoshida with:
Yoko Yoshida Japan
Munther J. Hussain United Kingdom
Nasir Mahmud Ireland
Ludger Leifeld Germany
Yuri Etani Japan
Sinikka Koskinen Finland
V. Bonnevie‐Nielsen Denmark
M. A. Blajchman Canada
Ivar Følling Norway
M.F. Bassendine United Kingdom
Mazen Alsahli relative to Yoko Yoshida Japan Yoko Yoshida's profile →
Citations per field
00.5×3.0×
Yoko Yoshida · 1×
Citations per year

Countries citing papers authored by Mazen Alsahli

Since Specialization
Citations

This map shows the geographic impact of Mazen Alsahli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mazen Alsahli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mazen Alsahli more than expected).

Fields of papers citing papers by Mazen Alsahli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mazen Alsahli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mazen Alsahli. The network helps show where Mazen Alsahli may publish in the future.

Co-authorship network of co-authors of Mazen Alsahli

This figure shows the co-authorship network connecting the top 25 collaborators of Mazen Alsahli. A scholar is included among the top collaborators of Mazen Alsahli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mazen Alsahli. Mazen Alsahli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 3
2 119
3 89
4 127
5 52
6
Hypoglycemia, chronic kidney disease and diabetes
2
7 35
8 29
9 38
10 435
11 44
12 3
13 10
14 1
15 21
16 172
17 4

About Mazen Alsahli

Mazen Alsahli is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Genetics, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Diabetes Treatment and Management (5 papers) and Diabetes Management and Research (5 papers). The work is most often cited by research in Genetics (606 citations), Endocrinology, Diabetes and Metabolism (291 citations) and Immunology (341 citations). Mazen Alsahli has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include John E. Gerich, Kenneth R. Falchuk, Mark A. Peppercorn, Richard J. Farrell, Pierre Michetti, Yoon‐Tae Jeen, John Gerich, Samir A. Shah, Julian C. Cooper and R. J. Farrell. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology and Mayo Clinic Proceedings.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026